Inverse dC (Bz) CNA CPG
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of a 2'-fluoro modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
CPG for the incorporation of cholesterol at the 3' end of an oligonucleotide, with a triethylene glycol spacer.
CPG for the incorporation of amino-C6 at the 3' end of an oligonucleotide, with phthalimide (PT) protection.
CPG for incorporation of a locked nucleic acid G analogue at the 3' end of an oligonucleotide.
CPG for incorporation of cholesterol at 3' end of an oligonucleotide, with a dR spacer
CPG for the incorporation of thiol-C3 at the 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |